50% off Premium Yearly

TSE:JWEL
This summary was created by AI, based on 2 opinions in the last 12 months.
Jamieson Wellness (JWEL-T) is gaining favorable attention from experts primarily due to its core business's strength and the potential for unsolicited takeout offers. With a strategic expansion into markets like China, the company is differentiating itself through its commitment to quality, which positions it favorably against competitors. Additionally, Jamieson has a solid track record, having increased its dividend at a remarkable rate of 14% over the last five years, alongside a modest yield of 2.55%. Analysts also highlight the rising valuations of private vitamin/mineral companies, suggesting a market trend that could benefit Jamieson's valuation in the long run. Despite recent stock appreciation, it is believed that the odds of a takeout are greater than what the market currently expects, making this an appealing investment.
(A Top Pick July 20/17, Up 56%) He looks for companies that dominate their market. This is the number one consumer healthcare brand. More than the next 5 largest competitors combined. It was a show-me story at the time. It needs to penetrate other geographical markets like China for continued growth. It is fairly valued at this price.
It is the most prominent name in wellness and vitamins. This company is becoming globally entrenched, but it is very Canadian. It will carry on growing. It has had great numbers. They are at the low end of the price range as holistic people would be willing to pay three times more for the pills. He thinks it has growth potential. (Analysts’ target: $22.25).
It is the MacDonald’s of the vitamin business. It is the number one Canadian consumer health brand. They have more market share than their 5 biggest peers combined. They have exposure in China. He thinks it will be a success-IPO story like DOL-T. It is now going to be a show-me story as they grow their top line.
He likes the trend towards health and wellness through supplements and protein shakes. The company has been given a license to sell their branded product in China. His fund will continue to hold this stock.